基于18F-FDG PET/CT的影像组学模型预测非小细胞肺癌病理分化程度:一项多中心研究
该多中心研究纳入4个中心182例非小细胞肺癌患者,从18F-FDG PET/CT图像提取影像组学特征,建立临床模型、影像组学模型及联合临床特征的列线图模型,用ROC曲线评估预测病理分化程度的能力。列线图模型在训练集、内部验证集、外部验证集的AUC分别为0.86、0.83、0.77,诊断性能相对优于临床模型和影像组学模型。
要点
- 列线图模型在外部验证集AUC为0.77(95%CI=0.62-0.92),诊断性能相对优于临床模型和影像组学模型。
- 影像组学模型在训练集AUC为0.84(95%CI=0.77-0.92),内部验证集为0.81(95%CI=0.67-0.95)。
- 临床特征联合影像组学特征构建的列线图在三个队列中AUC均高于单一模型。
核心结论
- 基于18F-FDG PET/CT的影像组学模型对预测非小细胞肺癌分化程度显示出良好能力,联合影像组学特征与临床特征的列线图诊断性能相对更好。
研究设计与样本
- 多中心研究,纳入4个中心共182例非小细胞肺癌患者,从18F-FDG PET/CT图像提取影像组学特征,建立临床模型、影像组学模型和列线图模型,用ROC曲线分析评估预测能力。
诊断标准与关键数值
- 临床模型在训练集、内部验证集、外部验证集的AUC分别为0.74(95%CI=0.64-0.84)、0.64(95%CI=0.46-0.81)、0.74(95%CI=0.60-0.88)。
- 影像组学模型在训练集、内部验证集、外部验证集的AUC分别为0.84(95%CI=0.77-0.92)、0.81(95%CI=0.67-0.95)、0.74(95%CI=0.58-0.89)。
- 列线图在训练集、内部验证集、外部验证集的AUC分别为0.86(95%CI=0.78-0.93)、0.83(95%CI=0.70-0.96)、0.77(95%CI=0.62-0.92)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To explore the value of 2-[18F]-fluoro-2-deoxy-d-glucose (FDG) positron-emission tomography (PET)/computed tomography (CT)-based radiomics model for predicting the degree of pathological differentiation in non-small-cell lung cancer (NSCLC).
MATERIALS AND METHODS: Clinical characteristics of 182 NSCLC patients from four centres were collected, and radiomics features were extracted from 18F-FDG PET/CT images. Three logistic regression prediction models were established: clinical model; radiomics model; and nomogram combining radiomics signatures and clinical features. The predictive ability of the models was assessed using receiver operating characteristics curve analysis.
RESULTS: Patients from centre 1 were assigned randomly to the training and internal validation cohorts (7:3 ratio); patients from centres 2-4 served as the external validation cohort. The area under the curve (AUC) values for the clinical model in the training, internal validation, and external validation cohort were 0.74 (95% confidence interval [CI] = 0.64-0.84), 0.64 (95% CI = 0.46-0.81), and 0.74 (95% CI = 0.60-0.88), respectively. In the training (AUC: 0.84 [95% CI = 0.77-0.92]), internal validation (AUC: 0.81 [95% CI = 0.67-0.95]), and external validation cohorts (AUC: 0.74 [95% CI = 0.58-0.89]), the radiomics model showed good predictive ability for differentiation. Compared to the clinical and radiomics models, the nomogram has relatively better diagnostic performance, and the AUC values for nomogram in the training, internal validation, and external validation cohort were 0.86 (95% CI = 0.78-0.93), 0.83 (95% CI = 0.70-0.96), and 0.77 (95% CI = 0.62-0.92), respectively.
CONCLUSIONS: The 18F-FDG PET/CT-based radiomics model showed good ability for predicting the degree of differentiation of NSCLC. The nomogram combining the radiomics signature and clinical features has relatively better diagnostic performance.
引用
- Liu F, Xiang Z, Li Q, et al. 18F-FDG PET/CT-based radiomics model for predicting the degree of pathological differentiation in non-small cell lung cancer: a multicentre study. Clin Radiol. 2023. PMID: 37884401. doi:10.1016/j.crad.2023.09.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。